Perfromance Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Buy
752
+9
+1% +$4.53K 0.01% 150
2025
Q4
$347K Hold
743
0.01% 154
2025
Q3
$316K Buy
743
+1
+0.1% +$388 0.01% 163
2025
Q2
$284K Buy
742
+1
+0.1% +$360 0.01% 153
2025
Q1
$256K Hold
741
0.01% 146
2024
Q4
$222K Hold
741
0.01% 169
2024
Q3
$301K Buy
741
+10
+1% +$3.66K 0.01% 146
2024
Q2
$235K Hold
731
0.01% 142
2024
Q1
$244K Buy
+731
New +$223K 0.01% 138
2023
Q3
Sell
-710
Closed -$212K 174
2023
Q2
$212K Buy
+710
New +$197K 0.01% 175
2022
Q2
Sell
-840
Closed -$211K 174
2022
Q1
$211K Buy
+840
New +$211K 0.01% 167

Other funds holding HCA

Perfromance Wealth Partners's HCA Position: Q1 2026 in Review

Perfromance Wealth Partners increased its HCA Healthcare (HCA) stake by 1.2% in Q1 2026, buying an estimated $4.53K and bringing the position to 752 shares worth $356K. The position accounts for 0.01% of the portfolio, ranked #150.

Perfromance Wealth Partners first reported a position in HCA in Q1 2022 and has held it in 11 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Perfromance Wealth Partners held 752 shares of HCA Healthcare worth $356K as of Q1 2026.
  • Perfromance Wealth Partners bought 9 HCA Healthcare shares in Q1 2026, an estimated $4.53K.
  • HCA Healthcare made up 0.01% of Perfromance Wealth Partners's portfolio in Q1 2026, its #150 holding.
  • Perfromance Wealth Partners first reported a position in HCA Healthcare in Q1 2022 and has held it in 11 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.